Cognivia Raises €15.5M to Advance AI-Driven Clinical Trial Innovations.

Cognivia leverages a combination of patient psychology quantification and advanced machine learning to revolutionize clinical trials, aiming to optimize therapeutic outcomes and accelerate drug development

Source: cognivia

Company Name: Cognivia
Location: Mont-Saint-Guibert, Belgium
Sector: Healthcare/AI
Funding Details: Raised €15.5M from Vesalius Biocapital IV, SFPIM (Société Fédérale de Participations et d’Investissement), and WE (Wallonie Entreprendre).
Purpose of Investment: To deploy predictive clinical trial solutions that enhance the speed and effectiveness of developing new treatments by understanding the relationship between patient traits and treatment outcomes.
Leadership: Led by CEO Dominique Demolle.

Product: Cognivia’s AI and ML technologies integrate quantitative psychological data to improve the efficacy measurement in clinical trials, predicting patient behavior and treatment response.

About Company: Cognivia leverages a combination of patient psychology quantification and advanced machine learning to revolutionize clinical trials, aiming to optimize therapeutic outcomes and accelerate drug development.

Pelotero Secures $3M in Seed Funding for AI-Powered Player Intelligence Platform

Pelotero is pioneering the integration of AI with sports coaching to create personalized training experiences.

Brenig Therapeutics Secures $65M in Series A Funding for Neurology Drug Development

Brenig Therapeutics is a neurology-focused drug development company utilizing an AI/ML-based discovery platform,

Monarch Tractor Secures $133M in Series C Funding for AI-Driven Agricultural Expansion

Monarch Tractor is pioneering the transformation of the agricultural industry by integrating AI and autonomous technology into its electric vehicle solutions, thus enhancing farm management and sustainability practices globally.

Read next